QSAR Analysis of 1,4-Dihydropyridine Calcium Channel Antogonists

被引:0
|
作者
Kahraman, Pinar [1 ]
Turkay, Metin [1 ]
机构
[1] Koc Univ, Coll Engn, Rumelifeneri Yolu, TR-34450 Istanbul, Turkey
来源
17TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING | 2007年 / 24卷
关键词
Drug design; QSAR analysis; data classification; mixed-integer programming;
D O I
暂无
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
The early prediction of activity related characteristics of drug candidates is an important problem in drug design. The activities of drug candidates are classified as low or high depending on their IC50 values. Since experimental determination of IC50 values for a vast number of molecules is both time consuming and expensive, computational approaches are employed. In this paper, we present a novel approach to classify the activities of drug molecules. We use hyper-boxes classification method in combination with partial least squares regression to determine the most relevant molecular descriptors of the drug molecules in efficient classification. The effectiveness of the approach is illustrated on DHP derivatives. The results indicate that the proposed approach outperforms the other approaches reported in the literature.
引用
收藏
页码:977 / 982
页数:6
相关论文
共 50 条
  • [1] QSAR STUDY ON 1,4-DIHYDROPYRIDINE AS CALCIUM CHANNEL ANTAGONISTS
    Singh, J.
    Shaik, B.
    Shukla, S. K.
    Sharma, M.
    Singh, S.
    Agrawal, V. K.
    OXIDATION COMMUNICATIONS, 2013, 36 (03): : 761 - 777
  • [2] QSAR study of 1,4-dihydropyridine calcium channel antagonists based on gene expression programming
    Si, Hong Zong
    Wang, Tao
    Zhang, Ke Jun
    Hu, Zhi De
    Fan, Bo Tao
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (14) : 4834 - 4841
  • [3] Obtaining antibodies to 1,4-Dihydropyridine calcium channel antagonists
    A. A. Burkin
    M. A. Burkin
    Applied Biochemistry and Microbiology, 2008, 44 : 323 - 327
  • [4] Obtaining antibodies to 1,4-dihydropyridine calcium channel antagonists
    Burkin, A. A.
    Burkin, M. A.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 2008, 44 (03) : 323 - 327
  • [5] Quantum chemical-QSAR study of some newly synthesized 1,4-dihydropyridine calcium channel blockers
    Safarpour, MA
    Hemmateenejad, B
    Miri, R
    Jamali, M
    QSAR & COMBINATORIAL SCIENCE, 2004, 22 (9-10): : 997 - 1005
  • [6] MODULATION OF CALCIUM-CHANNEL FUNCTION WITH THE 1,4-DIHYDROPYRIDINE STRUCTURE
    SCHRAMM, M
    TOWART, R
    JOURNAL OF PHYSIOLOGY-LONDON, 1984, 349 (APR): : P53 - P53
  • [7] QSAR and classification study of 1,4-dihydropyridine calcium channel antagonists based on least squares support vector machines
    Yao, Xiaojun
    Liu, Huanxiang
    Zhang, Ruisheng
    Liu, Mancang
    Hu, Zhide
    Panaye, A.
    Doucet, J. P.
    Fan, Botao
    MOLECULAR PHARMACEUTICS, 2005, 2 (05) : 348 - 356
  • [8] A flavone 1,4-dihydropyridine calcium antagonist
    Özbey, S
    Kendi, E
    Ayhan, GK
    Ertan, R
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1999, 55 : 678 - 681
  • [9] PURIFICATION OF THE CARDIAC 1,4-DIHYDROPYRIDINE RECEPTOR CALCIUM-CHANNEL COMPLEX
    RENGASAMY, A
    PTASIENSKI, J
    HOSEY, MM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 126 (01) : 1 - 7
  • [10] Synthesis and Evaluation of 1,4-Dihydropyridine Derivatives with Calcium Channel Blocking Activity
    Bladen, Chris
    Gunduz, Miyase Gozde
    Simsek, Rahime
    Safak, Cihat
    Zamponi, Gerald W.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2014, 466 (07): : 1355 - 1363